Loading
Latest filing published 11 Dec 2017 for CanniMed Therapeutics Inc., €21k.
No signal scores available.
This profile gathers the share dealings of Richard Hoyt in CanniMed Therapeutics Inc. Over a trading history stretching from 1 November 2016 to 25 January 2017, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 11 December 2017 came the latest disclosure, a transaction for €21k in CanniMed Therapeutics Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations